Empirical Finance, LLC Vertex Pharmaceuticals Inc Transaction History

Empirical Finance, LLC

  • $1.7 Billion
  • Q3 2024

A detailed history of Empirical Finance, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Empirical Finance, LLC holds 8,916 shares of VRTX stock, worth $3.64 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
8,916
Previous 8,726 2.18%
Holding current value
$3.64 Million
Previous $4.09 Million 1.37%
% of portfolio
0.24%
Previous 0.26%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$460.0 - $505.78 $87,400 - $96,098
190 Added 2.18%
8,916 $4.15 Million
Q2 2024

Jul 30, 2024
SELL
$392.81 - $485.53 $238,042 - $294,231
-606 Reduced 6.49%
8,726 $4.09 Million
Q1 2024

May 06, 2024
BUY
$407.69 - $446.08 $147,583 - $161,480
362 Added 4.04%
9,332 $3.9 Million
Q3 2023

Nov 02, 2023
BUY
$338.18 - $362.46 $292,525 - $313,527
865 Added 10.67%
8,970 $3.12 Million
Q2 2023

Jul 27, 2023
BUY
$314.42 - $351.91 $294,925 - $330,091
938 Added 13.09%
8,105 $2.85 Million
Q1 2023

Apr 05, 2023
BUY
$283.23 - $323.1 $97,714 - $111,469
345 Added 5.06%
7,167 $2.26 Million
Q4 2022

Jan 24, 2023
BUY
$285.76 - $321.48 $155,739 - $175,206
545 Added 8.68%
6,822 $1.97 Million
Q3 2022

Nov 04, 2022
BUY
$273.83 - $305.53 $282,592 - $315,306
1,032 Added 19.68%
6,277 $1.82 Million
Q2 2022

Aug 01, 2022
BUY
$234.96 - $292.55 $64,144 - $79,866
273 Added 5.49%
5,245 $1.48 Million
Q1 2022

Apr 21, 2022
BUY
$221.42 - $260.97 $117,352 - $138,314
530 Added 11.93%
4,972 $1.3 Million
Q4 2021

Feb 04, 2022
BUY
$177.01 - $223.45 $208,694 - $263,447
1,179 Added 36.13%
4,442 $975,000
Q3 2021

Nov 12, 2021
BUY
$181.39 - $202.99 $33,738 - $37,756
186 Added 6.04%
3,263 $592,000
Q2 2021

Aug 10, 2021
BUY
$187.49 - $221.1 $80,245 - $94,630
428 Added 16.16%
3,077 $620,000
Q4 2020

Feb 02, 2021
BUY
$207.01 - $276.09 $96,466 - $128,657
466 Added 21.35%
2,649 $626,000
Q3 2020

Oct 28, 2020
BUY
$255.65 - $303.1 $558,083 - $661,667
2,183 New
2,183 $594,000
Q3 2020

Oct 26, 2020
SELL
$255.65 - $303.1 $434,093 - $514,663
-1,698 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$225.48 - $295.8 $382,865 - $502,268
1,698 New
1,698 $493,000
Q2 2020

Jul 20, 2020
SELL
$225.48 - $295.8 $334,161 - $438,375
-1,482 Closed
0 $0
Q1 2020

Apr 16, 2020
BUY
$199.77 - $247.81 $106,477 - $132,082
533 Added 56.16%
1,482 $353,000
Q4 2019

Jan 27, 2020
BUY
$166.71 - $223.91 $158,207 - $212,490
949 New
949 $208,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email